Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients.
about
A review of indocyanine green fluorescent imaging in surgeryConvergence of nanotechnology and cancer prevention: are we there yet?Interstitial photoacoustic sensor for the measurement of tissue temperature during interstitial laser phototherapy.Synergistic effects of glycated chitosan with high-intensity focused ultrasound on suppression of metastases in a syngeneic breast tumor modelAssessment of thermal effects of interstitial laser phototherapy on mammary tumors using proton resonance frequency method.Enhanced tumor treatment using biofunctional indocyanine green-containing nanostructure by intratumoral or intravenous injectionInCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunityIn vitro activity studies of hyperthermal near-infrared nanoGUMBOS in MDA-MB-231 breast cancer cells.In situ photoimmunotherapy for cutaneous granuloma caused by itraconazole-resistant Candida guilliermondii.Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer.Improvement of DC vaccine with ALA-PDT induced immunogenic apoptotic cells for skin squamous cell carcinoma.N-dihydrogalactochitosan as a potent immune activator for dendritic cells.Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccinePhotodynamic therapy for gynecological diseases and breast cancerDendritic cell-based immunotherapy: a basic review and recent advances.Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response.Determination of temperature distribution in tissue for interstitial cancer photothermal therapy.Laser immunotherapy for cutaneous squamous cell carcinoma with optimal thermal effects to enhance tumor immunogenicity.Hemichrome Determination by Thermal Lensing with Polyethylene Glycols for Signal Enhancement in Aqueous Solutions
P2860
Q21285140-311B5DBF-47F9-4778-A9A5-F536FE1846D4Q28386699-37A11941-A61E-47A5-8855-C695A7693882Q30411779-A84B517A-CFB2-40BF-87CB-5A268EF97063Q30439573-DD63A260-4FF8-46FD-835E-452AACD85B1BQ34108844-2100D9AE-4F3C-476F-8AF7-66255E97359DQ34158431-8979B84F-AD44-4738-AAF3-C98AE541979AQ35108944-13DAEC82-5E0A-449F-B01C-23FCDE90FC04Q35197317-5A8FEFFD-F563-4A93-A9F0-30DE5219C505Q36058170-2D350B81-6CFF-45DF-816A-D4EB0685429EQ36140389-6ACB4604-2551-4826-BAA4-F25B7296E65CQ36231990-91C5CF26-5B0E-4880-955A-55495108CDAAQ36234323-D79AF9A0-E844-42EE-8C96-6C520521AAC2Q36702887-C98A3AFC-00C5-4390-97FD-3FFEB867B662Q36814295-F5E2FD35-E69A-458D-AD1D-6B3965CA6CA9Q38665350-05294227-95FF-4819-9D07-1F732B32B77CQ41702460-51C8E2BA-8C29-4A18-ACC1-B0739DA6353FQ47772370-EA24AF39-39EC-4BBD-BF18-DCDA5A5C098EQ51747472-6A6E73C5-B22C-43E0-9399-E799ADEA518DQ58281072-93189D05-F553-4737-A4EB-89FDF9CE5CFD
P2860
Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Preliminary safety and efficac ...... static breast cancer patients.
@ast
Preliminary safety and efficac ...... static breast cancer patients.
@en
type
label
Preliminary safety and efficac ...... static breast cancer patients.
@ast
Preliminary safety and efficac ...... static breast cancer patients.
@en
prefLabel
Preliminary safety and efficac ...... static breast cancer patients.
@ast
Preliminary safety and efficac ...... static breast cancer patients.
@en
P2093
P2860
P356
P1476
Preliminary safety and efficac ...... static breast cancer patients.
@en
P2093
Gabriela L Ferrel
John A Lunn
Maria C Guerra
Orn Adalsteinsson
Robert E Nordquist
Tomas Hode
Wei R Chen
Xiaosong Li
P2860
P304
P356
10.1039/C0PP00306A
P577
2011-03-04T00:00:00Z